Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.

Autor: Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Sharma K; Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Borlaug BA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA., Butler J; Baylor Scott and White Research Institute, Dallas, TX, USA.; Department of Medicine, University of Mississippi, Jackson, MS, USA., Davies M; Diabetes Research Centre, University of Leicester, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Leicester, UK., Kitzman DW; Department of Internal Medicine, Sections on Cardiovascular Medicine and Geriatrics/Gerontology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Patel S; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA., Chinnakondepalli KM; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA., Einfeldt MN; Novo Nordisk A/S, Søborg, Denmark., Jensen TJ; Novo Nordisk A/S, Søborg, Denmark., Rasmussen S; Novo Nordisk A/S, Søborg, Denmark., Asleh R; Heart Institute, Hadassah University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Ben-Gal T; Heart Failure Unit, Cardiology Department, Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.

Publikováno v: European heart journal [Eur Heart J] 2024 Sep 14; Vol. 45 (35), pp. 3254-3269.

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.

Autor: Butler J; Baylor Scott & White Research Institute, Dallas, TX, USA; Department of Medicine, University of Mississippi, Jackson, MS, USA., Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Borlaug BA; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA., Abildstrøm SZ; Novo Nordisk, Søborg, Denmark., Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK; National Institute for Health and Care Research Leicester Biomedical Research Centre, Leicester, UK., Hovingh GK; Novo Nordisk, Søborg, Denmark., Kitzman DW; Department of Cardiovascular Medicine and Section on Geriatrics and Gerontology, Wake Forest School of Medicine, Winston-Salem, NC, USA., Møller DV; Novo Nordisk, Søborg, Denmark., Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Einfeldt MN; Novo Nordisk, Søborg, Denmark., Lindegaard ML; Novo Nordisk, Søborg, Denmark., Rasmussen S; Novo Nordisk, Søborg, Denmark., Abhayaratna W; College of Health and Medicine, Australian National University, Canberra, ACT, Australia., Ahmed FZ; Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Ben-Gal T; Heart Failure Unit, Department of Cardiology, Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Chopra V; Max Super Speciality Hospital, Saket, New Delhi, India., Ezekowitz JA; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada., Fu M; Section of Cardiology, Department of Medicine, Sahlgrenska University Hospital-Ostra, Gothenburg, Sweden., Ito H; Department of General Internal Medicine 3, Kawasaki Medical School, Okayama, Japan., Lelonek M; Department of Noninvasive Cardiology, Medical University of Lodz, Lodz, Poland., Melenovský V; Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic., Merkely B; Heart and Vascular Centre, Semmelweis University, Budapest, Hungary., Núñez J; Hospital Clínico Universitario de Valencia, INCLIVA, Universidad de Valencia, Valencia, Spain; Centro de Investigación Biomédica en Red Cardiovascular, Valencia, Spain., Perna E; Instituto de Cardiologia J F Cabral, Corrientes, Argentina., Schou M; Department of Cardiology, Herlev-Gentofte Hospital, Hellerup, Denmark; Department of Clinical Medicine, University of Copenhagen, Herlev, Denmark., Senni M; Azienda Socio Sanitaria Territorial Papa Giovanni XXIII, Bergamo, Italy., Sharma K; Heart Failure & Cardiac Transplantation, Johns Hopkins University Heart Failure with Preserved Ejection Fraction Program, Johns Hopkins Hospital, Baltimore, MD, USA., van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Von Lewinski D; Medical University of Graz, Graz, Austria., Wolf D; Cardiology and Angiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA; University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA. Electronic address: mkosiborod@saint-lukes.org.

Publikováno v: Lancet (London, England) [Lancet] 2024 Apr 27; Vol. 403 (10437), pp. 1635-1648. Date of Electronic Publication: 2024 Apr 07.

Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort Study.

Autor: Einfeldt MN; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark., Olsen AS; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark., Kristensen SL; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark., Khalid U; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark., Faber J; Department of Endocrinology, Herlev-Gentofte University Hospital, Herlev, Denmark.; Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Torp-Pedersen C; Department of Health Science and Technology, University of Aalborg, Aalborg Denmark., Gislason GH; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.; Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.; The Danish Heart Foundation, Copenhagen, Denmark.; The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark., Selmer C; Department of Endocrinology, Herlev-Gentofte University Hospital, Herlev, Denmark.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2019 May 01; Vol. 104 (5), pp. 1725-1734.